Quote Atoltivimab
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection.
Read more
€0.00
(tax incl.)
Reference:
HY-P99343
Brand: